Literature DB >> 16474108

Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.

J H Henriksen1, S Fuglsang, F Bendtsen, S Møller.   

Abstract

BACKGROUND AND AIMS: Arterial hypertension is a common disorder. Hyperkinetic circulation and reduced effective volaemia are central elements in the haemodynamic dysfunction in cirrhosis. The aim of the present study was to investigate whether cirrhotic patients with arterial hypertension are normokinetic and normovolaemic or whether they reveal the same circulatory dysfunction as their normotensive counterparts.
MATERIAL AND METHODS: Thirty three patients with arterial hypertension were identified among 648 patients with cirrhosis: 14 in Child class A, 12 in class B, and seven in class C. Controls were 130 normotensive cirrhotic patients, 19 controls with normal arterial blood pressure and without liver disease, and 16 patients with essential arterial hypertension. All groups underwent haemodynamic investigation with determination of cardiac output (CO), plasma volume (PV), central blood volume (CBV), hepatic venous pressure gradient (HVPG), hepatic blood flow (HBF), arterial compliance (AC), and systemic vascular resistance (SVR) in the supine position.
RESULTS: Liver function, as evaluated by galactose elimination capacity, indocyanine green clearance, HBF, and Child score, was significantly better in hypertensive cirrhotics than in their normotensive counterparts (p<0.05-0.01) but portal pressure was similar (HVPG 13 v 15 mm Hg; NS). AC was significantly lower and normal in the arterial hypertensive cirrhotic group (1.07 v 1.39 mm Hg/ml; p<0.02) and SVR was significantly higher and normal (1475 v 1020 dynxs/cm5; p<0.01). Arterial hypertensive cirrhotic patients were hyperdynamic (CO 6.80 v 7.14 l/min; NS) and central hypovolaemic (CBV 19.8 v 20.6 ml/kg; NS), as were normotensive patients, but differences were found in relation to arterial blood pressure. Whereas arterial pressure was inversely correlated with CO, PV, and Child score in the normotensive group (p< 0.01), the same correlations were either direct or insignificant in arterial hypertensive cirrhotics.
CONCLUSION: Arterial hypertensive cirrhotic patients are hyperkinetic and central hypovolaemic, in common with their normotensive counterparts, but vasodilatation is reduced and regulation of arterial blood pressure may be less deranged.

Entities:  

Mesh:

Year:  2006        PMID: 16474108      PMCID: PMC1856081          DOI: 10.1136/gut.2005.064329

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

Review 1.  Cardiovascular dysfunction in cirrhosis. Pathophysiological evidence of a cirrhotic cardiomyopathy.

Authors:  S Møller; J H Henriksen
Journal:  Scand J Gastroenterol       Date:  2001-08       Impact factor: 2.423

2.  Hormonal aspects of the relation of liver cirrhosis to essential hypertension.

Authors:  F Veglio; G Pinna; R Melchio; F Rabbia; M Panarelli; D Schiavone; P Mulatero; L Chiandussi
Journal:  Clin Exp Hypertens A       Date:  1992

3.  An evaluation of hypertension and liver disease in an alcoholic service.

Authors:  H F LOYKE; R CUTARELLI
Journal:  Am J Med Sci       Date:  1960-09       Impact factor: 2.378

Review 4.  Genetic predisposition to salt-sensitivity: a systematic review.

Authors:  Esther Beeks; Alfons G H Kessels; Abraham A Kroon; Melanie M van der Klauw; Peter W de Leeuw
Journal:  J Hypertens       Date:  2004-07       Impact factor: 4.844

5.  Reduction of hypertension after liver disease.

Authors:  H F LOYKE
Journal:  Arch Intern Med       Date:  1962-07

6.  Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique.

Authors:  M Kiszka-Kanowitz; J H Henriksen; S Møller; F Bendtsen
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

7.  Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-02-26       Impact factor: 4.052

8.  Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.

Authors:  Guillermo Fernández-Varo; Josefa Ros; Manuel Morales-Ruiz; Pilar Cejudo-Martín; Vicente Arroyo; Manel Solé; Francisca Rivera; Juan Rodés; Wladimiro Jiménez
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease.

Authors:  Kim Brinch; Søren Møller; Flemming Bendtsen; Ulrik Becker; Jens H Henriksen
Journal:  J Hepatol       Date:  2003-07       Impact factor: 25.083

10.  Hepatic blood flow determination. A comparison of 99mTc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man.

Authors:  J H Henriksen; K Winkler
Journal:  J Hepatol       Date:  1987-02       Impact factor: 25.083

View more
  9 in total

Review 1.  Liver cirrhosis and arterial hypertension.

Authors:  Jens H Henriksen; Soren Moller
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

2.  Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial.

Authors:  Hisashi Hidaka; Takahide Nakazawa; Akitaka Shibuya; Tsutomu Minamino; Juichi Takada; Yoshiaki Tanaka; Yusuke Okuwaki; Masaaki Watanabe; Wasaburo Koizumi
Journal:  J Gastroenterol       Date:  2011-08-18       Impact factor: 7.527

3.  Outcome of hepatectomy for hepatocellular carcinoma in patients with renal dysfunction.

Authors:  Takeo Toshima; Ken Shirabe; Shohei Yoshiya; Jun Muto; Toru Ikegami; Tomoharu Yoshizumi; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-05       Impact factor: 3.647

Review 4.  Evaluation of liver transplant candidates with non-alcoholic steatohepatitis.

Authors:  James Philip G Esteban; Amon Asgharpour
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

5.  Prevalence of arterial hypertension in cirrhosis of liver.

Authors:  Prabhu P Rajesh; R Srinivasan; V Jayanthi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

6.  Mean arterial pressure drop is an independent risk factor of hepatorenal syndrome in patients with HBV-ACLF.

Authors:  Xingrong Zheng; Yunwen Lian; Peipei Wang; Lihua Zheng; Hewei Wu; Jiaxin Lin; Xiyao Chen; Zhiliang Gao; Liang Peng; Chan Xie
Journal:  Eur J Gastroenterol Hepatol       Date:  2022-05-01       Impact factor: 2.566

7.  Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis.

Authors:  Eduardo Vilar Gomez; Ana Torres Gonzalez; Luis Calzadilla Bertot; Ali Yasells Garcia; Yoan Sanchez Rodriguez; Yadina Martinez Perez
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

8.  NGF (-198C > T, Ala35Val) and p75NTR (Ser205Leu) gene mutations are associated with liver function in different histopathological profiles of the patients with chronic viral hepatitis in the Brazilian Amazon.

Authors:  Leonn Mendes Soares Pereira; Ednelza da Silva Graça Amoras; Simone Regina Souza da Silva Conde; Sâmia Demachki; Eduardo José Melo Dos Santos; Sandra Souza Lima; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Mol Med       Date:  2020-01-29       Impact factor: 6.354

9.  Splenectomy with Portoazygous Disconnection for Correction of Systemic Hemodynamic Disorders in Hepatic Cirrhosis Patients with Portal Hypertension: A Prospective Single-Center Cohort Study.

Authors:  Dao-Bing Zeng; Liang Di; Qing-Liang Guo; Jing Ding; Xiao-Fei Zhao; Shi-Chun Lu
Journal:  Can J Gastroenterol Hepatol       Date:  2020-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.